SPP1 and neoplasm: According to our scRNA-seq data, most of the tumor cells either expressed S100P (23.95%) or SPP1 (60.05%), while only 10.01% and 5.98% tumor cells showed double negativity or double positivity, respectively (Supplementary Fig. 2e, f).